ICU Medical (NASDAQ:ICUI) Trading Down 6% Following Insider Selling

ICU Medical, Inc. (NASDAQ:ICUI) traded down 6% during trading on Tuesday after an insider sold shares in the company. The company traded as low as $156.95 and last traded at $157.78. 155,950 shares changed hands during trading, a decline of 43% from the average session volume of 273,648 shares. The stock had previously closed at $167.81.

Specifically, COO Christian B. Voigtlander sold 1,962 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $169.08, for a total value of $331,734.96. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. KeyCorp raised their price target on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a report on Wednesday, November 13th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Jefferies Financial Group began coverage on shares of ICU Medical in a research report on Monday, October 14th. They set a “hold” rating and a $183.00 price target for the company. Raymond James boosted their target price on ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research note on Thursday, September 12th. Finally, Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, ICU Medical presently has a consensus rating of “Moderate Buy” and a consensus price target of $173.00.

ICU Medical Stock Up 1.3 %

The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The stock has a 50 day simple moving average of $175.61 and a 200-day simple moving average of $146.51. The firm has a market cap of $3.91 billion, a PE ratio of -34.96 and a beta of 0.66.

Hedge Funds Weigh In On ICU Medical

A number of hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in shares of ICU Medical by 0.5% during the first quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier’s stock valued at $263,226,000 after purchasing an additional 11,991 shares during the last quarter. State Street Corp grew its position in shares of ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock worth $165,384,000 after purchasing an additional 77,506 shares in the last quarter. Geode Capital Management LLC raised its position in shares of ICU Medical by 9.6% during the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after buying an additional 48,106 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in ICU Medical by 21.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 311,542 shares of the medical instruments supplier’s stock worth $36,996,000 after purchasing an additional 55,588 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in ICU Medical by 10.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock valued at $54,868,000 after buying an additional 27,927 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.